Higher anticholinergic burden from medications is associated with significant increase in markers of inflammation in the EPIC‐Norfolk prospective population‐based cohort study-Reference-Cited by-同舟云学术

Higher anticholinergic burden from medications is associated with significant increase in markers of inflammation in the EPIC‐Norfolk prospective population‐based cohort study

Published:2022-02-27 Issue:7 Volume:88 Page:3297-3306
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Sanghavi Ria¹^ORCID,Pana Tiberiu A.²³^ORCID,Mamayusupova Hulkar⁴,Maidment Ian⁵^ORCID,Fox Chris⁴^ORCID,Boekholdt S. Matthijs⁶^ORCID,Mamas Mamas A.⁷^ORCID,Wareham Nicholas J.⁸^ORCID,Khaw Kay‐Tee⁹^ORCID,Myint Phyo K.²³^ORCID

Affiliation:

1. College of Life Sciences University of Leicester UK

2. Aberdeen Diabetes and Cardiovascular Centre, School of Medicine, Medical Sciences & Nutrition University of Aberdeen Aberdeen Scotland UK

3. Ageing Clinical and Experimental Research Team University of Aberdeen UK

4. Norwich Medical School University of East Anglia Norwich UK

5. Pharmaceutical & Clinical Pharmacy Research Group Aston University Birmingham UK

6. Department of Cardiology Amsterdam University Medical Centre, location AMC Amsterdam The Netherlands

7. Keele Cardiovascular Research Group Keele University Stoke‐on‐Trent UK

8. MRC Epidemiology Unit Cambridge UK

9. Clinical Gerontology Unit, Department of Public Health & Primary Care University of Cambridge Cambridge UK

Funder

Cancer Research UK